Exploration of Neuroprotective Therapy

Open Access Meta-Analysis

Efficacy and safety of CDP-choline, cerebrolysin, MLC601, and edaravone in recovery of patients with acute ischemic strokes: a meta-analysis

Shafiq Dexter B. Abou Zaki, Johnny K. Lokin

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:398–408

DOI: https://doi.org/10.37349/ent.2023.00057

This article belongs to the special issue Therapeutic Targets for Neuroprotection in Ischemic Stroke

Full Text PDF

15263 86 2

Open Access Review

Exploration of transcutaneous vagus nerve stimulation as a treatment option for adjuvant cancer and heart failure therapy

Niklas Frank ... Carola Y. Förster

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:363–397

DOI: https://doi.org/10.37349/ent.2023.00056

This article belongs to the special issue Intervention of Neuroimmune Responses

Full Text PDF

22469 111 8

Open Access Review

Stem cell therapy in neurological disorders: promises and concerns

Said Hachimi-Idrissi

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:346–362

DOI: https://doi.org/10.37349/ent.2023.00055

This article belongs to the special issue Therapeutic Targets for Neuroprotection in Ischemic Stroke

Full Text PDF

17981 148 9

Open Access Review

Neuroprotective astroglial response to neural damage and its relevance to affective disorders

José Javier Miguel-Hidalgo

Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:328–345

DOI: https://doi.org/10.37349/ent.2023.00054

Full Text PDF

6874 38 12

Open Access Original Article

Aldh1a1 and additional markers of dopamine cell heterogeneity in substantia nigra and ventral tegmental area identified as preserved in two transgenic α-synuclein mouse models of neurodegenerative disease

Bianca Vlcek ... Åsa Wallén-Mackenzie

Published: October 30, 2023 Explor Neuroprot Ther. 2023;3:299–327

DOI: https://doi.org/10.37349/ent.2023.00053

Full Text PDF

8978 70 1

Open Access Review

The effects of post-translational modifications on alpha-synuclein aggregation and immune cell activation in Parkinson’s disease

Zaina Khan, Yoo Jin Jung

Published: October 26, 2023 Explor Neuroprot Ther. 2023;3:281–298

DOI: https://doi.org/10.37349/ent.2023.00052

Full Text PDF

9886 88 9

Open Access Original Article

Cognitive recovery in psychiatric disorders: transdiagnostic interdisciplinary intervention in a high intensity partial psychiatric in-patient unit

Ana Isabel De Santiago-Díaz ... Elsa Gómez-Ruiz

Published: October 26, 2023 Explor Neuroprot Ther. 2023;3:268–280

DOI: https://doi.org/10.37349/ent.2023.00051

Full Text PDF

4755 38 0

Open Access Original Article

Cannabinoid CB₂ receptor ligands disrupt the sequential regulation of p-MEK1/2 to p-ERK1/2 in mouse brain cortex

Glòria Salort ... Jesús A. García-Sevilla

Published: October 24, 2023 Explor Neuroprot Ther. 2023;3:258–267

DOI: https://doi.org/10.37349/ent.2023.00050

This article belongs to the special issue The Urgent Need for New Hypotheses to Develop Effective Therapeutic Tools Against Alzheimer's Disease

Full Text PDF

3959 45 1